TABLE 1.

Recipient and donor factors

	Alemtuzamab pretreated	Conventional immunosuppression
n	76	84
Case accrual	9/12/02 → 4/30/03	9/12/02 → 4/30/03
Recipient age (yr)	52±10.2	53±10.6
Male/female	27/49	29/55
MELD at transplant	14.2±5.7	14.9±7.3
Hepatitis C	38 (50%)	26 (31%)
Status 1 patients	1 (1%)	7 (8%)
Donor age	47±15.9	51±18.2
Cold ischemia	11.9±3.36 hr	11.8±3.43 hr
HLA mismatch	4.5 ±1.2	4.5±1.1

HLA, human leukocyte antigen; MELD, Model for End-Stage Liver Disease.